$2 / month

Comment and reply across TML.

Start or manage membership

Most pulsed

Latest from other desks

tml.the modern leap
Health / Medical Research

Shoulder Injuries Stay Rare After Vaccination

A Kaiser Permanente Southern California study published in JAMA Internal Medicine on Tuesday, November 17, 2026, reviewed more than 1.8 million vaccinations given to 1.4 million adults from August 2023 through April 2024. Researchers found 110 cases of shoulder injury related to vaccine administration after 596,614 COVID vaccinations, a rate of 1.8 per 10,000, and 142 cases after 1.2 million flu vaccinations, a rate of 1.15 per 10,000. After adjustment, COVID vaccination carried a 63 percent higher relative risk, which the authors translate to about 7 additional cases per 100,000 vaccinations. This is observational record data, not a randomized trial.

TML Health DeskNov 17, 2:26 PM ET · 2 min read

Edited and fact-checked by Stephen Sprague

A nurse administers a vaccine into a patient's arm (archive). The Kaiser Permanente study defines the injury by shoulder symptoms in the vaccinated arm that begin within seven days and last at least 30 days. Photo: Rhoda Baer, National Cancer Institute, via Wikimedia Commons.
Summary

A 63 percent relative increase sounds alarming until it's converted. The absolute gap is about 7 extra cases in 100,000 vaccinations, and the authors and an accompanying editorial both say the proven benefits of either vaccine outweigh the risk.

Tap a passage. React to the part that matters.

A nurse at a Kaiser Permanente clinic in Southern California put a needle in an upper arm, and the medical record followed that arm for months. Researchers reviewed more than 1.8 million vaccinations given to 1.4 million adults between August 2023 and April 2024.

The study appeared in JAMA Internal Medicine on Tuesday. Chengyi Zheng and colleagues counted cases of shoulder injury related to vaccine administration, known as SIRVA. The condition means shoulder symptoms in the vaccination arm that begin within seven days of the shot, last for at least 30 days and appear to have no other possible cause.

COVID vaccinations produced 110 cases out of 596,614 shots. That's 0.018 percent, or 1.8 cases per 10,000 vaccinations. Flu vaccinations produced 142 cases out of 1.2 million shots. That's 0.012 percent, or 1.15 cases per 10,000 vaccinations.

Adjustment widened the relative gap without changing the absolute one. After the team adjusted for confounding factors, COVID vaccination was associated with a 63 percent higher relative risk of shoulder injury. The authors convert that figure themselves. It equals approximately 7 additional cases per 100,000 vaccinations compared with flu vaccination.

Age narrowed the difference to a statistical wash. Among adults 65 and older, incidence was 2.1 cases per 10,000 COVID vaccinations against 1.6 per 10,000 high-dose flu vaccinations. The researchers report that this difference wasn't statistically significant, so a clinic vaccinating seniors can't read a proven gap into those two numbers.

Technique is the suspected mechanism, not the vaccine formula. The most likely cause is an inadvertent injection into the shoulder joint or surrounding structures instead of the deltoid muscle, and that placement can trigger inflammation and persistent pain. Needle trauma, vaccine-specific inflammatory responses and individual susceptibility may also contribute. For the person in the chair, arm anatomy and injection placement matter more than the brand on the vial.

The authors state their limits directly. Most participants received the Pfizer and BioNTech mRNA COVID vaccine, so the findings may not generalize to other products. The study also didn't measure specific aspects of injection technique, even though the team stresses that recommended intramuscular practice helps prevent the injury, especially in older adults whose anatomy changes with age.

An accompanying editorial by Alexander Chaitoff of the University of Michigan Medical School and Mitchell H. Katz of NYC Health and Hospitals puts the count in context. SIRVA is rare after both vaccines, they write, and enduring local complications are likely outweighed by the proven benefits of vaccination. SIRVA has sat on the National Vaccine Injury Compensation Program injury table since 2017, so a patient with a qualifying case has a defined route to file.

Sources

The conversation

A little more perspective.

Reading is free. Verified members can comment and reply for $2 a month.

The conversation.

Loading comments…

Keep your curiosity going.

Some links here are affiliate links. If you buy through one, we might make a commission — it never changes what you pay. As an Amazon Associate I earn from qualifying purchases.